Skip to main content

Animations

MJFF Publications

6401 - 6410 of 8808 Results
Title
Year
  • Year
  • 2015
  • 2025
  • 2023
  • 2021
  • 2023
  • 2021
  • 2024
  • 2020
  • 2024
  • 2017
  • Summary Details
    RESTRICTED
    Title: Intranasal administration of glial-derived neurotrophic factor (GDNF) rapidly and significantly increases whole-brain GDNF level in rats
    Journal Name: Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.016
    Citation Count: 45
  • Summary Details
    OPEN
    Title: An Experimental Approach for Investigating Freezing of Gait in Parkinson’s Disease Using Virtual Reality and Neural Sensing: A Pilot Study
    Journal Name: Sensors
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/s25134036
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Disrupted‐in‐schizophrenia 1 protein aggregates in cerebrospinal fluid are elevated in patients with first‐episode psychosis
    Journal Name: Psychiatry and Clinical Neurosciences
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/pcn.13594
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Telemedicine in an Academic Movement Disorders Center during COVID-19
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.20099
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Intensive whole-brain 7T MRI case study of volitional control of brain activity in deep absorptive meditation states
    Journal Name: Cerebral Cortex
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/cercor/bhad408
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Clearing the Smoke: What Protects Smokers from Parkinson's Disease?
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.29707
    Citation Count: 21
  • Summary Details
    OPEN
    Title: O-GlcNAcylation inhibits the oligomerization of alpha-synuclein by declining intermolecular hydrogen bonds through a steric effect
    Journal Name: Physical Biology
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/1478-3975/abb6dc
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders
    Journal Name: Genetics in Medicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.gim.2024.101251
    Citation Count: 0
  • Summary Details
    OPEN
    Title: D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats
    Journal Name: British Journal of Pharmacology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/bph.13937
    Citation Count: 23
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.